Biodesix, Inc.
BDSX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $56,625 | $41,357 | $91,592 | $224,303 |
| - Cash | $16,704 | $20,728 | $17,603 | $26,245 |
| + Debt | $72,928 | $72,141 | $62,285 | $61,976 |
| Enterprise Value | $112,849 | $92,770 | $136,274 | $260,034 |
| Revenue | $21,768 | $20,018 | $17,958 | $20,429 |
| % Growth | 8.7% | 11.5% | -12.1% | – |
| Gross Profit | $17,662 | $15,987 | $14,255 | $16,087 |
| % Margin | 81.1% | 79.9% | 79.4% | 78.7% |
| EBITDA | -$5,235 | -$8,158 | -$8,011 | -$5,101 |
| % Margin | -24% | -40.8% | -44.6% | -25% |
| Net Income | -$8,716 | -$11,468 | -$11,101 | -$8,251 |
| % Margin | -40% | -57.3% | -61.8% | -40.4% |
| EPS Diluted | -1.16 | -1.6 | -1.6 | -1.2 |
| % Growth | 27.5% | 0% | -33.3% | – |
| Operating Cash Flow | -$8,879 | -$6,568 | -$8,602 | -$4,096 |
| Capital Expenditures | -$48 | -$51 | -$137 | -$884 |
| Free Cash Flow | -$8,927 | -$6,619 | -$8,739 | -$4,980 |